迅速診断市場：製品別、処方別、用途別、エンドユーザー別、地域別-規模、シェア、展望、機会分析、2023年～2030年

迅速診断検査は、通常30分以内に結果が出る使い勝手の良い検査です。30分以内に実施可能で、病原体の存在を迅速かつ正確に検出する迅速なフィールドテストです。迅速な結果によって、ヘルスケア専門家/従事者は情報に基づいた判断を迅速に下し、地域レベルで患者の生命を守ることができます。

市場力学：

感染症/慢性疾患の有病率の上昇、COVID-19（パンデミック）の発生、ポイントオブケア診断の使用率の上昇、有利な政府の取り組み、早期診断に関する人々の意識の高まりは、予測期間中に世界の迅速診断市場の成長を後押しすると予想される主要因です。

例えば、2022年3月、Brain Chemistry LabsとArlington Scientificは、使いやすい迅速検査キットを開発するために提携しました。この迅速検査キットは、筋萎縮性側索硬化症（ALS）という致命的な麻痺性疾患を引き起こすシアノバクテリアのブルームに存在する毒素であるB-メチルアミノ-L-アラニン（BMAA）の存在を検出するものです。

本調査の主な特徴

• 本レポートでは、世界の迅速診断市場を詳細に分析し、2022年を基準年とした予測期間（2023-2030年）の市場規模およびCAGRを提供しています。
• また、さまざまなセグメントにおける潜在的な収益機会を解明し、この市場に対する魅力的な投資提案マトリクスを解説しています。
• また、市場促進要因、抑制要因、機会、新製品の発売または承認、市場動向、地域展望、主要企業が採用する競争戦略に関する重要な考察を提供します。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略など、以下のパラメータに基づいて、世界の迅速診断市場の主要企業をプロファイルしています。
• この調査の一部としてカバーされている主要企業は、Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.。
• 本レポートから得られる知見は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた決定を下すことを可能にするでしょう。
• 本レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
• 利害関係者は、世界の迅速診断市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次：

第1章 調査の目的と前提条件

• 調査の目的
• 前提条件
• 略語

第2章 市場展望

• レポート概要
  • 市場の定義と範囲
• エグゼクティブサマリー
• コヒーレント・オポチュニティ・マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 慢性疾患/感染症の有病率の上昇
  • 厳しい規制と迅速診断の課題
  • COVID-19の発生（世界的パンデミック）
• 影響分析
• 主なハイライト
• 規制のシナリオ
• 製品発売/承認
• PEST分析
• PORTERの分析
• 合併・買収シナリオ

第4章 迅速診断の世界市場-コロナウイルス（COVID-19）パンデミックの影響

• COVID-19の疫学について
• 供給サイドと需要サイドの分析
• 経済的影響

第5章 迅速診断の世界市場、製品別、2017年～2030年

• 消耗品
• 機器/分析装置

第6章 迅速診断の世界市場、処方箋別、2017-2030年

• プロフェッショナル診断
• 家庭用/OTCベース検査

第7章 迅速診断の世界市場：用途別、2017年～2030年

• 血糖値検査
• 循環器系検査
• 感染症検査
• 血液凝固検査
• 血液学的検査
• がん検診
• 乱用薬物検査
• 妊娠・不妊・排卵検査

第8章 迅速診断の世界市場、エンドユーザー別、2017年～2030年

• 病院・診療所
• ラボ
• 個人／在宅ケア環境
• その他

第9章 迅速診断の世界市場、地域別、2017年～2030年

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ地域

第10章 競合情勢

• Abbott
• Danaher
• Quidel
• BD
• LifeScan
• Siemens Healthineers
• F. Hoffmann-La Roche
• Ascensia Diabetes Care Holdings

第11章 セクション

• 調査手法について
• 出版社について

Rapid diagnostic tests are easy-to-use tests that provide quick results, usually 30 in minutes or less. These are quick field tests that can be performed in under 30 minutes and detect the presence of a pathogen quickly and accurately. Rapid results enable healthcare professionals/workers to make informed decisions quickly and protect the lives of their patients at the community level.

Market Dynamics:

Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.

For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of B-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).

Key features of the study:

• This report provides in-depth analysis of the global rapid diagnostics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global rapid diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global rapid diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid diagnostics market.

Detailed Segmentation:

• Global Rapid Diagnostics Market, By Product:
  • Consumables
  • Instruments/Analysers
• Global Rapid Diagnostics Market, By Prescription:
  • Professional Diagnostics
  • At-Home/OTC-Based Testing
• Global Rapid Diagnostics Market, By Application:
  • Blood Glucose Testing
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drug of Abuse Testing
  • Pregnancy and Fertility/Ovulation Testing
• Global Rapid Diagnostics Market, By End User:
  • Hospitals and Clinics
  • Laboratories
  • Individuals/Home Healthcare Settings
  • Others
• By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Abbott
  • Danaher
  • Quidel
  • BD
  • LifeScan
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Ascensia Diabetes Care Holdings

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Prescription
  • Market Snapshot By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in prevalence of chronic/infectious disease
  • Stringent regulations and rapid diagnostics challenges
  • The outbreak of COVID-19 (global pandemic)
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Rapid Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Rapid Diagnostics Market, By Product, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Instruments/Analysers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

6. Global Rapid Diagnostics Market, By Prescription, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Professional Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• At-Home/OTC-Based Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

7. Global Rapid Diagnostics Market, By Application, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Blood Glucose Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Cardiometabolic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Infectious Disease Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Blood Coagulation Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Hematology Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Cancer Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Drug of Abuse Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Pregnancy and Fertility/Ovulation Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

8. Global Rapid Diagnostics Market, By End User, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Individuals/Home Healthcare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

9. Global Rapid Diagnostics Market, By Geography, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)

10. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quidel
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BD
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LifeScan
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ascensia Diabetes Care Holdings
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us